Introduction {#S5}
============

With over 3.4 million current residents, South Asians, individuals from India, Pakistan, Nepal, Bangladesh, and Sri Lanka, comprise the fastest growing ethnic group in the United States (US) ([@R1]). Compared to other race/ethnic groups, South Asians have higher rates of type 2 diabetes (DM) ([@R2]) and cardiovascular disease (CVD) ([@R3], [@R4]). Some hypothesize that the higher rates of metabolic disorders and CVD are due to differences in body composition with higher amounts of fat in organs and tissues where fat is not intended to be stored (called ectopic fat) and/or lower levels of lean muscle mass ([@R5]).

Compared to Whites, South Asians have higher amounts of total body fat for a given body mass index (BMI) ([@R6]). Abnormalities in glucose and lipid metabolism that are seen in Europeans with a BMI of 30 kg/m^2^ are seen at a lower BMI (21-22.5 kg/m^2^) in South Asians ([@R7]). Furthermore, for a given level of total body fat, South Asians have higher amounts of abdominal adipose tissue including subcutaneous, visceral and hepatic fat, and less lean muscle mass ([@R8], [@R9]), as well as abnormal levels of hormones secreted from adipose tissue (adipokines) ([@R10], [@R11]). Compared to Whites, South Asians have a lower capacity to store fat in subcutaneous adipose, and therefore, some have proposed the adipose tissue overflow hypothesis, which states that excess fat overflows to these ectopic compartments ([@R12]). In the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE), ectopic fat in combination with decreased lean muscle mass and an abnormal adipokine profile was associated with insulin resistance and higher cardiometabolic risk in South Asians with a non-obese BMI ([@R9]).

Prior studies investigating differences in body composition, ectopic fat depots, and adipokines in South Asians compared to another ethnic group have been small. None have performed a comprehensive evaluation of several ectopic fat depots, lean muscle mass and adipokines simultaneously among multiple different race/ethnic groups. A comprehensive evaluation of body composition that includes several measures of ectopic fat and lean mass in combination with adipokine levels, serving as measures of adipocyte dysfunction, is critical to better assessing overall metabolic risk in the South Asian population. Therefore, using data from two large well-phenotyped cohorts, Mediators of Atherosclerosis in South Asians Living in America (MASALA) and Multi-Ethnic Study of Atherosclerosis (MESA), we compared body composition and adipokines amongst five race/ethnic groups. Our hypothesis was that compared to other race/ethnic groups in the US, South Asians would have greater amounts of ectopic fat (visceral fat area, intermuscular fat area, pericardial fat volume and lower hepatic attenuation), less lean muscle mass and a less favorable adipokine profile. Additionally, we hypothesized that by controlling for the differences in body composition, we would be able to explain the differences in adipokine levels between South Asians and the other four race/ethnic groups.

Methods {#S6}
=======

Study Populations {#S7}
-----------------

We performed a cross-sectional analysis of harmonized data from two community-based cohorts: MASALA and MESA. Since we did not detect a strong correlation between age and body composition variables (r ≤ 0.35), all individuals in the MASALA study (ages 40-84 years) were included for the purposes of this analysis (n=906) and were compared to the four MESA racial/ethnic groups. Data from the MESA baseline exam was used for pericardial fat volume and hepatic attenuation analyses and included 2,622 Whites, 803 Chinese Americans, 1,893 African Americans, and 1,496 Latinos. Data from an ancillary study from MESA Exams 2 and 3 was used for abdominal fat, intermuscular fat, lean mass and adipokine analyses, which included a random sample from each of the four race/ethnic groups with a total of 785 Whites, 251 Chinese Americans, 407 African Americans, and 501 Latinos.

The institutional review boards at the sites conducting both the MASALA and MESA studies approved both study protocols. Informed consent was obtained from all study subjects.

MASALA Study {#S8}
------------

The MASALA study is a community-based cohort of South Asian adults without known CVD, which was modeled on MESA ([@R13], [@R14]). Study participants were sampled from two geographic locations, the nine counties of the San Francisco Bay Area and the greater Chicago area. Clinical sites for the study were at the University of California, San Francisco (UCSF) and Northwestern University (NWU). A total of 906 subjects were recruited between October 2010 and March 2013. We have previously published detailed methods for the MASALA Study ([@R14]).

Eligibility criteria for MASALA included self-identification of South Asian ethnicity, age between 40-84 years, and ability to speak and read English, Hindi or Urdu. ([@R14]). MASALA used identical exclusion criteria as the MESA Study which included a diagnosis of a heart attack, stroke or transient ischemic attack, heart failure, angina, nitroglycerin medication use, any prior cardiovascular procedures, current atrial fibrillation, cancer treatment, shortened life expectancy, impaired cognition, plans to move out of the geographic vicinity of the study site in the next 5 years, living in a nursing home, or weight \>300 lbs. ([@R14]).

Participants were assisted by trained bilingual study staff to complete detailed questionnaires for demographic information and behaviors (including tobacco and alcohol use) ([@R14]). Physical activity was assessed using the Typical Week\'s Physical Activity Questionnaire ([@R15]).

Blood pressure was measured after a 5 minute seated rest using an automated blood pressure machine (V100 Vital Sign Monitor; GE Healthcare, Fairfield, CT, USA). Three blood pressures were recorded and the average of the last two readings used as mean systolic and diastolic blood pressure. A systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg or use of any anti-hypertensive medication was used to define hypertension.

After a requested 12 hour fast, fasting blood samples were obtained. We measured total cholesterol, triglycerides, high-density lipoprotein cholesterol using enzymatic methods and low density lipoprotein was calculated. Fasting plasma glucose was measured by hexokinase method (Quest Labs, San Jose, CA). We used the American Diabetes Association criteria to define diabetes, by fasting glucose ≥126 mg/dl and/or use of a diabetes medication. We measured adiponectin and resistin using Millipore Luminex adipokine A panel (EMD Millipore; Billerica, MA). Inter-assay coefficient of variation was 2.3-4.1% for adiponectin and 3.3-5.5% for resistin.

### Body Composition {#S9}

We measured participant weight on a standard balance-beam scale or digital weighing scale. Height was measured using a stadiometer. BMI was calculated by weight in kg divided by height in (meters)^2^. Trained study coordinators measured waist circumference using a flexible tape measure at the site of maximum waist circumference midway between the lower ribs and the anterior superior iliac spine. The average of two measurements was used for analysis.

Computed tomography scans of the abdomen (CT, Philips Medical Systems, Andover, MA, USA; Toshiba Medical Systems, Tustin, CA, USA; Siemens Medical Solution, Malvern, PA, USA) were used to calculate abdominal visceral and subcutaneous fat area intermuscular fat area, and abdominal lean muscle mass area. A CT technician obtained a lateral scout image of the abdomen to establish position between the L4 and L5 vertebrae. A single abdominal CT slice was obtained at this level and Medical Image Processing, Analysis, and Visualization (MIPAV) software was used to measure visceral and subcutaneous abdominal fat ([@R17]) at the University of California, San Diego body composition reading center. Visceral fat was demarcated by readers as those pixels with the appropriate Hounsfield Unit (HU) range inside the visceral cavity. Subcutaneous fat was defined as the tissue outside the visceral cavity but inside the body contour. Muscle segmentation was done as previously described ([@R18]). The four abdominal/back muscle groups from which fat and lean mass measurements were obtained included the psoas, paraspinous, oblique and rectus muscles. These muscles were highlighted by the readers and then deleted from the calculation of subcutaneous fat. Measurements from all four abdominal and back muscle groups were summed to obtain total intermuscular fat area and total lean muscle mass area.

Non-contrast cardiac CT images were obtained to quantify pericardial fat and hepatic attenuation using a cardiac-gated CT scanner: at UCSF, a Phillips 16D scanner or a Toshiba MSD Aquilion 64 and at NWU, a Siemens Sensation Cardiac 64 Scanner (Siemens Medical Solutions, Malvern, PA, USA) was used. The same reading center staff under the supervision of Dr. Jeffrey Carr performed all measurements of pericardial fat volume and hepatic attenuation. The CT scan range encompassed the entire heart and provided information on 45 mm of adipose tissue encasing the proximal coronary arteries. We first defined the 45 mm z-axis volume containing the proximal coronary arteries. The technician follows a set of regions of interest (ROI) pertaining to subcutaneous and pericardial fat within the 45 mm volume along with regions in the calibration phantom to calculate the range of Hounsfield units (HU) for adipose tissue. The technician segments the heart from the thorax by removing tissues beyond the lung using a deformable model-based edge detection method such as active contours or live wires to detect the boundary between the lung and fat around the heart ([@R19]-[@R21]).

CT images for hepatic attenuation were also interrogated using the MIPAV software at vertebral level T12-L1. Nine ROIs within homogenous portions of the liver at two levels were read, avoiding any vascular structures or other liver pathology. Measurement methods were similar to those used in MESA ([@R22]). Fatty liver was defined as having Hounsfield units \< 40.

MESA Study {#S10}
----------

The study design, eligibility, and methods for MESA have been previously published ([@R13]). MESA includes individuals from four racial/ethnic groups (Whites, African Americans, Chinese Americans, and Latinos)living in Forsyth County, North Carolina; Chicago, Illinois; Baltimore, Maryland; Los Angeles County, California; St. Paul, Minnesota; and New York, New York. Data from the baseline MESA examination (2000-2002) were used for hepatic attenuation and pericardial fat volume measurements; data from a body composition ancillary study done during exam 2 (2002-2004) and 3 (2004-2005) were used for the abdominal fat, intermuscular fat, lean mass, and adipokine measurements. Identical questionnaires for assessing sociodemographic characteristics and behaviors and identical protocols for seated blood pressure, anthropometry, and abdominal and cardiac CT scanning were used as described above for the MASALA study. Both studies used the same reading centers and protocols for measuring abdominal body composition, pericardial fat volume and hepatic attenuationfor ease of data harmonization.

Serum glucose was measured from fasting samples by the glucose oxidase method (Ortho Clinical Diagnostics, Johnson & Johnson). Similar assays were used to measure adiponectin and resistin (Millipore Luminex adipokine panel A) as for the MASALA study, and these adipokines measurement were conducted at the same research laboratory.

Statistical Analysis {#S11}
--------------------

Harmonized data from the MASALA and MESA study cohorts was used. Age- and sex-adjusted baseline characteristics of the MASALA participants and each of the MESA race/ethnic groups were obtained using regression standardization.

Multivariate general linear models were developed to examine the association between race/ethnicity and the following: subcutaneous fat area, visceral fat area, total intermuscular fat area, pericardial fat volume, hepatic attenuation, total lean muscle mass area, adiponectin and resistin. For the body fat measures, the models were adjusted in a stepwise manner: first for age, sex, site, alcohol use, smoking history, education, household income, exercise and BMI; then for hypertension and DM; and finally for HDL and triglycerides. The total lean muscle mass model and adipokine models were adjusted for age, sex, site, alcohol use, smoking history, education, household income, exercise, and BMI. The adipokine models were additionally adjusted for visceral fat area, total intermuscular fat area, subcutaneous fat area, pericardial fat volume, and hepatic attenuation. Additionally, to account for race/ethnic differences in height, a sensitivity analysis was done where the models were adjusted for height instead of BMI. Sex interaction by race was also investigated and sex-stratified analyses were also done. For the pericardial fat volume and hepatic attenuation models, baseline covariate data from the MESA study was used for sequential adjustments. For the abdominal fat, intermuscular fat, lean mass, and adipokine models, updated MESA covariate data from exam 2 and 3 were used for sequential adjustments.

All analyses were conducted using SAS version 9.4 (SAS Institute, Inc., Cary, NC, USA).

Results {#S12}
=======

South Asians in MASALA were younger (55±9 years for MASALA vs. 62±10 years in MESA) and MASALA included fewer women (46% women in MASALA vs. 52% in MESA) compared to those in other race/ethnic groups in MESA. Therefore age- and sex adjusted baseline characteristics of participants in the MASALA and MESA studies by race/ethnic group are shown in [Table 1](#T1){ref-type="table"}. Compared to other MESA groups, South Asians had a significantly higher level of education, higher household income, lower prevalence of smoking and alcohol use (except compared to Chinese Americans), and were less physically active. South Asians also had a higher prevalence of DM and hypertension (except compared to African Americans), lower adiponectin levels and higher resistin levels. South Asians had a lower BMI, weight and waist circumference compared to most other MESA groups, except compared to Chinese Americans who had the lowest means for these anthropometric indices.

[Figure 1a-e](#F1){ref-type="fig"} (and [Supplemental Table 1](#SD1){ref-type="supplementary-material"}) depict the mean ectopic fat measures after adjusting for age, sex, socioeconomic status, behavioral factors, BMI, and metabolic factors (DM, hypertension, HDL and triglycerides). Compared to African Americans, South Asians had less subcutaneous fat. South Asians had higher levels of visceral fat compared to Chinese Americans, African Americans, and Latinos but similar amounts compared to Whites. South Asians had higher levels of intermuscular fat and hepatic fat (ie lower hepatic attenuation) compared to all other race/ethnic groups. South Asians had less pericardial fat volume compared to Whites and Chinese Americans, but greater pericardial fat volume than African Americans. Pericardial fat volume was similar between South Asians and Latinos.

Analyses of lean muscle mass, adjusting for age, sex, socioeconomic status, behavioral factors, and BMI showed that South Asians had significantly less total lean abdominal/back muscle mass compared to all other ethnic groups after full adjustment ([Figure 1f](#F1){ref-type="fig"} and [Supplemental Table 1](#SD1){ref-type="supplementary-material"}).

Adiponectin levels were lower in South Asians after adjusting for age, sex, socioeconomic status, behavioral factors, BMI and all ectopic fat measures compared to all MESA groups except for Chinese Americans. However, resistin levels remained higher in South Asians compared to all other ethnic groups after full adjustment for all ectopic fat depots ([Figure 2](#F2){ref-type="fig"} and [Supplemental Table 1](#SD1){ref-type="supplementary-material"}).

In order to adjust for body size differences without possibly overadjusting for fat or lean body mass, we performed a sensitivity analysis adjusting for height instead of BMI ([Supplemental table 2](#SD2){ref-type="supplementary-material"}). Similar results were obtained for the analyses of lean mass, adipokines and hepatic attenuation and only some slight but statistically significant differences were noted in the other ectopic fat measures.

Given evidence of sex interaction by race for several of the ectopic fat measures and adipokines, sex-stratified analyses were performed ([Supplemental table 3](#SD3){ref-type="supplementary-material"}). With few exceptions, body composition and adipokine patterns across ethnicities were similar in men and women, although similar levels of significance were not always observed.

Discussion {#S13}
==========

In this cross-sectional study of two community-based cohort studies of multiple ethnic groups residing in the US and without cardiovascular disease, South Asians overall had less favorable body composition and adipokine profiles compared to most other US race/ethnic groups. Interestingly, while South Asians did not consistently have higher levels of subcutaneous and visceral fat area compared to other race/ethnic groups, they had greater total intermuscular fat area, lower hepatic attenuation and less total lean muscle mass compared to all other ethnic groups. Furthermore, even after adjusting for all measures of ectopic fat, South Asians had lower adiponectin levels compared to all other ethnic groups, except Chinese Americans, and higher resistin levels compared to all other groups.

The prevalence of obesity-related diseases such as DM, hypertension, and coronary artery disease is high in South Asians ([@R23]). A recent comparison of the MASALA and MESA cohorts found that US South Asians have a higher prevalence of diabetes compared to other ethnic groups ([@R2]). In the MASALA pilot study, we showed that while South Asians only had a modestly elevated BMI (mean 26.1 kg/m^2^), they had relatively high levels of total and regional adiposity, including subcutaneous, visceral and hepatic fat ([@R24]). Studies in South Asians have demonstrated that visceral adiposity is associated with insulin resistance (IR), increased inflammatory markers, the metabolic syndrome and cardiovascular risk ([@R25], [@R26]). Therefore, it is thought that despite having a non-obese BMI, having greater amounts of ectopic fat contributes to an increased risk of obesity-related diseases in South Asians ([@R23]).

While our findings show that there are some race/ethnic differences in visceral and subcutaneous fat, our observations differ from what has been reported in other South Asian studies conducted in Europe and Canada. The M-CHAT study found that compared to Europeans, South Asians had greater amounts of subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) for a given amount of total body fat, although at extremely high values of body fat mass, no differences were detected ([@R8]). South Asian men and women also had greater total body fat and abdominal fat for a given BMI compared to Europeans and Pacific Islanders ([@R27]). And differences in metabolic risk factors were explained by greater VAT in South Asians compared to Europeans ([@R28]). Some studies conducted in the US have also found that compared to Whites, Asian Indians have higher levels of SAT and VAT for a given BMI ([@R29], [@R30]). Our findings may differ from prior studies due to differences in age and socioeconomic, immigration and behavioral differences between South Asians and Whites in the US vs. those in Europe or Canada.

Ectopic fat stores including intermuscular fat, hepatic fat, and pericardial fat are also important for cardiometabolic risk. Intermuscular adipose tissue is implicated in metabolic dysfunction and IR ([@R31]). We found that South Asians had the highest total intermuscular fat area compared to all other groups. Only one other study has investigated differences in intermuscular fat between South Asians and other ethnic groups and found that South Asians had less or similar amounts of thigh intermuscular fat compared to Europeans ([@R32]). Since we measured abdominal front and back wall intermuscular fat, these findings are not directly comparable to our findings.

Non-alcoholic fatty liver disease (NAFLD) is associated with several features of the metabolic syndrome in South Asians ([@R33]). We found that South Asians had lower hepatic attenuation (greater hepatic fat content) compared to all other ethnic groups. There are few studies comparing liver attenuation in South Asians to other ethnic groups. The mol-SHARE study found that South Asians had more liver fat than Caucasians ([@R9]). However, this ethnic difference was attenuated after adjustment for adipocyte size and fat distribution ([@R9]). Studies evaluating other ethnic groups, including prior studies of the MESA cohort, have found that compared to Whites, Hispanics had a higher odds and African Americans had a lower odds of fatty liver ([@R22], [@R34]). These race/ethnic differences are thought to be due to differences in lifestyle, insulin resistance, genetics, and distribution of adiposity ([@R34]).

Interestingly, we found that South Asians had less or similar pericardial fat volume compared to all ethnic groups except African Americans. To our knowledge, this is the first study to investigate pericardial fat in South Asians. Pericardial fat is associated with obesity--related insulin resistance ([@R35]), which has also been shown in the MESA cohort ([@R36]). Ongoing investigations will examine pericardial fat associations with metabolic and CVD outcomes in the MASALA cohort.

While increased adiposity increases the risk of metabolic disorders and CVD, lower lean mass also plays a role. Since lean mass is predominantly skeletal muscle mass, a target for insulin action, higher levels of lean mass are associated with greater insulin sensitivity ([@R37]) and reduced muscle mass has been associated with decreased insulin sensitivity in Asian Indian men ([@R23]). We found that South Asians had the lowest total lean mass area compared to all other ethnic groups. These findings are consistent with those from prior studies ([@R27], [@R29], [@R38]), including the mol-SHARE study, which found that South Asian men and women had less total body lean mass compared to Caucasians ([@R9]). Why South Asians have less lean muscle mass than other race/ethnic groups and understanding the role of physical activity, the biology of lean muscle mass and its role in metabolic risk are key areas for future investigation.

Adipokines are associated with metabolic risk as low levels of adiponectin and high levels of resistin have been implicated in insulin resistance and obesity ([@R39], [@R40]). We found that adiponectin was lower in South Asians compared to Whites, African Americans and Latinos while resistin was higher in South Asians compared to all other groups. These findings are consistent with those from prior studies ([@R41]-[@R43]). The mol-SHARE study found that South Asians had lower adiponectin levels than Whites, although this difference was accounted for by increased adipocyte area in South Asians versus Whites ([@R9]). To our knowledge, other studies comparing resistin levels between South Asians and other ethnic groups have not been conducted. We expected that accounting for differences in body composition would explain the differences in adipokine levels between South Asians vs. other groups, however, the differences remained significant. The robust differences in these adipokine levels among South Asians suggest that adipokines may independently influence downstream metabolic risk.

This study has several strengths as it is the first study to perform a comprehensive analysis of body composition and adipokines among five ethnic groups in the US using data from two large cohorts with harmonized data. In addition, it includes several radiographic measures of body composition including novel measures of ectopic fat. Limitations include inability to adjust for comparable measures of dietary intake between the two cohorts to determine the role of diet in body composition differences although measures of socioeconomic status may serve as a surrogate for diet. In addition, the prevalence of obesity in 2000-2005 during the MESA data collection and 2010-2013 for the MASALA data collection may be different and may have introduced some differences between the two cohorts. Finally, while the MASALA Study does not include a nationally representative sample of South Asians, it is representative of the middle-older aged South Asian population in the US. However, our findings may not be generalizable to the younger US South Asian population or to South Asians in other diaspora settings.

In conclusion, US South Asians have high levels of intermuscular and hepatic fat, less lean muscle mass and less favorable adipokine profiles compared to other US race/ethnic groups. These differences may partially account for the increased predisposition to insulin resistance, metabolic disorders and diabetes in South Asians. Prospective follow-up of the MASALA study cohort will provide additional insight into how these ethnic differences in body composition and adipokines influence differences in the development of type 2 diabetes and cardiovascular disease.
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![(A-F): Fully-Adjusted Body Composition Measures Across Ethnic Groups\
Body composition was compared across ethnic groups in a multivariate model. Covariates included: age, sex, study site, alcohol use, smoking history, socioeconomic status, exercise and BMI. For abdominal and ectopic fat measures, additional covariates included: diabetes, hypertension, HDL, and triglycerides. Data represent mean and 95% confidence interval. (A -- Subcutaneous fat area, B -- Visceral fat area, C -- Total intermuscular fat area, D -- Pericardial fat volume, E -- Hepatic attenuation, F -- Total lean muscle mass area.)\
For pericardial fat and hepatic attenuation analyses, N for MESA ethnic groups are as follows: White -- 2622, Chinese American -- 803, African American -- 1893, and Latino -- 1496. For subcutaneous fat area, visceral fat area, total intermuscular fat area, and total lean muscle mass area analyses, N for MESA ethnic groups are as follows: Whites -- 785, Chinese Americans -- 251, African Americans -- 407, and Latino -- 501.\
\*p \< 0.001: Results of pairwise comparisons of body composition between South Asians and each of the other race / ethnic groups.\
\*\*p \< 0.05: Results of pairwise comparisons of body composition between South Asians and each of the other race / ethnic groups.\
^\#^p \< 0.01: Results of pairwise comparisons of body composition between South Asians and each of the other race / ethnic groups.\
Abbreviations: BMI -- body mass index, HDL -- high-density lipoprotein, HU -- Hounsfield units.](nihms727608f1){#F1}

![Fully-Adjusted Adipokine Levels Across Ethnic Groups\
Left: Adiponectin (ng/mL)\
Right: Resistin (ng/mL)\
Adipokine levels were compared across ethnic groups in a multivariate model. Covariates included: age, sex, study site, alcohol use, smoking history, socioeconomic status, exercise, BMI, subcutaneous fat area, visceral fat area, total intermuscular fat area, pericardial fat volume and hepatic attenuation. Data represent mean and 95% confidence interval.\
For these analyses, N for MESA ethnic groups are as follows: Whites -- 785, Chinese Americans -- 251, African Americans -- 407, and Latino -- 501.\
\*p \< 0.001: Results of pairwise comparisons of adipokine levels (adiponectin and resistin) between South Asians and each of the other race / ethnic groups.\
^\#^p \< 0.01: Results of pairwise comparisons of body composition between South Asians and each of the other race / ethnic groups.](nihms727608f2){#F2}

###### Age- and Sex-Adjusted Baseline characteristics[\*](#TFN1){ref-type="table-fn"} of MASALA and MESA[\#](#TFN2){ref-type="table-fn"} study participants by race/ethnicity

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                      South Asian\   White\        p-value    Chinese\      p-value    African\      p-value    Latino\       p-value    Overall p-\
                                       (n=906)        (n=2622)                 American\                American\                (n=1496)                 value
                                                                               (n=803)                  (n=1893)                                          
  ------------------------------------ -------------- ------------- ---------- ------------- ---------- ------------- ---------- ------------- ---------- -------------
  **Socioeconomic Status**                                                                                                                                

                                                                                                                                                          

  Education (≥Bachelor\'s degree)      85 (83-88)     50 (49-52)    \< 0.001   39 (36-43)    \< 0.001   35 (33-37)    \< 0.001   10 (8-11)     \< 0.001   \< 0.001

  Household Income(≥ \$75,000)         66 (63-69)     37 (35-39)    \< 0.001   17 (15-20)    \< 0.001   17 (15-18)    \< 0.001   7 (6-8)       \< 0.001   \< 0.001

                                                                                                                                                          

  **Behavioral Factors**                                                                                                                                  

                                                                                                                                                          

  Ever smoker                          17 (14-19)     56 (54-58)    \< 0.001   25 (22-28)    \< 0.001   55 (53-58)    \< 0.001   46 (44-48)    \< 0.001   \< 0.001

  Alcohol (≥ 1 drink/week)             31 (28-33)     65 (63-66)    \< 0.001   21 (19-24)    \< 0.001   53 (51-55)    \< 0.001   47 (44-49)    \< 0.001   \< 0.001

  Exercise (MET-min/week)              1246 (95)      2646 (55)     \< 0.001   1780 (99)     \< 0.001   2747 (64)     \< 0.001   2107 (72)     \< 0.001   \< 0.001

                                                                                                                                                          

  **Clinical and Metabolic Factors**                                                                                                                      

                                                                                                                                                          

  Systolic blood pressure (mmHg)       129.3 (0.7)    122.5 (0.4)   \< 0.001   123.8 (0.7)   \< 0.001   131.0 (0.4)   0.03       126.7 (0.5)   0.002      \< 0.001

  Diastolic blood pressure (mmHg)      72.9 (0.3)     70.3 (0.2)    \< 0.001   72.0 (0.3)    0.06       74.7 (0.2)    \< 0.001   71.5 (0.2)    0.001      \< 0.001

  Hypertension                         51 (48-54)     37 (35-38)    \< 0.001   36 (33-39)    \< 0.001   58 (56-60)    \< 0.001   42 (39-44)    \< 0.001   \< 0.001

  Fasting glucose (mmol/L)             5.79 (0.06)    5.01 (0.03)   \< 0.001   5.43 (0.06)   \< 0.001   5.50 (0.04)   \< 0.001   5.71 (0.04)   0.22       \< 0.001

  Diabetes                             24 (21-28)     6 (5-7)       \< 0.001   13 (10-15)    \< 0.001   17 (16-19)    \< 0.001   18 (16-20)    \< 0.001   \< 0.001

  Total cholesterol (mmol/L)           4.86 (0.03)    5.06 (0.02)   \< 0.001   4.99 (0.03)   0.004      4.89 (0.02)   0.33       5.12 (0.02)   \< 0.001   \< 0.001

  LDL-cholesterol (mmol/L)             2.86 (0.03)    3.03 (0.02)   \< 0.001   2.98 (0.03)   0.002      3.01 (0.02)   \< 0.001   3.09 (0.02)   \< 0.001   \< 0.001

  HDL-cholesterol (mmol/L)             1.33 (0.01)    1.35 (0.01)   0.23       1.28 (0.01)   0.002      1.34 (0.01)   0.40       1.23 (0.01)   \< 0.001   \< 0.001

  Triglycerides (mmol/L)               1.47 (0.03)    1.50 (0.02)   0.31       1.61 (0.03)   0.002      1.19 (0.02)   \< 0.001   1.77 (0.02)   \< 0.001   \< 0.001

  Adiponectin (ng/mL)                  12.8 (0.4)     23.5 (0.4)    \< 0.001   16.6 (0.7)    \< 0.001   17.3 (0.5)    \< 0.001   19.4 (0.5)    \< 0.001   \< 0.001

  Resistin (ng/mL)                     22.4 (0.3)     15.7 (0.3)    \< 0.001   14.9 (0.6)    \< 0.001   17.7 (0.5)    \< 0.001   16.0 (0.4)    \< 0.001   \< 0.001

                                                                                                                                                          

  **Anthropometric Measures**                                                                                                                             

                                                                                                                                                          

  Body mass index (kg/m^2^)            25.8 (0.2)     27.8 (0.1)    \< 0.001   24.0 (0.2)    \< 0.001   30.2 (0.1)    \< 0.001   29.4 (0.1)    \< 0.001   \< 0.001

  Weight (kg)                          67.9 (0.5)     79.5 (0.3)    \< 0.001   63.0 (0.6)    \< 0.001   85.9 (0.4)    \< 0.001   77.5 (0.4)    \< 0.001   \< 0.001

  Height (cm)                          162.4 (0.2)    169.1 (0.1)   \< 0.001   161.6 (0.2)   0.01       168.9 (0.1)   \< 0.001   161.8 (0.2)   0.04       \< 0.001

  Waist circumference (cm)             93.2 (0.5)     97.9 (0.3)    \< 0.001   87.0 (0.5)    \< 0.001   101.2 (0.3)   \< 0.001   100.6 (0.3)   \< 0.001   \< 0.001
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are presented as percent (95% confidence interval) or mean (standard error). Using South Asians as the reference group, pairwise comparisons were done using logistic model and analysis-of-variance (ANOVA).

Analyses done using data from baseline exam

Abbreviations: MET (metabolic equivalent), LDL (low-density lipoprotein), HDL (high-density lipoprotein)
